無料セミナー : 2018年10月2日『プレシジョン・メディシンの戦略的分析、将来動向予測』 BIS Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

体外診断 (IVD) の米国市場の展望:臨床化学・遺伝子検査・血液学的検査・組織学的検査および細胞診検査・免疫化学・感染症診断・微生物培養

United States In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

発行 GlobalData 商品コード 346087
出版日 ページ情報 英文 2729 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.56円で換算しております。
Back to Top
体外診断 (IVD) の米国市場の展望:臨床化学・遺伝子検査・血液学的検査・組織学的検査および細胞診検査・免疫化学・感染症診断・微生物培養 United States In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
出版日: 2017年12月01日 ページ情報: 英文 2729 Pages
概要

当レポートでは、米国の体外診断 (IVD) に用いられる試薬・機器・システムの市場について調査し、カテゴリーおよび主要製品区分別の収益規模の推移と予測、販売先のシェア実績、企業のシェア実績、主要企業の概要、パイプライン、企業間の財務取引の動向などをまとめています。

第1章 目次

第2章 イントロダクション

第3章 米国の体外診断市場

  • 収益の推移と予測
  • 収益構成:実績
  • 収益実績:カテゴリー別内訳
  • 収益の推移と予測:カテゴリー別の比較
  • 収益:これまでの推移
  • 収益:今後の予測
  • 収益による企業の市場シェア実績

第4章 米国の臨床化学市場

  • 収益構成:実績
  • 収益実績:カテゴリー別内訳
  • 収益:これまでの推移
  • 収益:今後の予測
  • 収益による販売先のシェア実績
  • 収益による企業の市場シェア実績

第5章 米国の遺伝子検査市場

  • 収益構成:実績
  • 収益実績:カテゴリー別内訳
  • 収益:これまでの推移
  • 収益:今後の予測
  • 収益による販売先のシェア実績
  • 収益による企業の市場シェア実績

第6章 米国の血液学的検査市場

  • 収益構成:実績
  • 収益実績:カテゴリー別内訳
  • 収益:これまでの推移
  • 収益:今後の予測
  • 収益による販売先のシェア実績
  • 収益による企業の市場シェア実績

第7章 米国の組織学的検査および細胞診検査市場

  • 収益構成:実績
  • 収益実績:カテゴリー別内訳
  • 収益:これまでの推移
  • 収益:今後の予測
  • 収益による販売先のシェア実績
  • 収益による企業の市場シェア実績

第8章 米国の免疫化学市場

  • 収益構成:実績
  • 収益実績:カテゴリー別内訳
  • 収益:これまでの推移
  • 収益:今後の予測
  • 収益による販売先のシェア実績
  • 収益による企業の市場シェア実績

第9章 米国の感染症診断市場

  • 収益構成:実績
  • 収益実績:カテゴリー別内訳
  • 収益:これまでの推移
  • 収益:今後の予測
  • 収益による販売先のシェア実績
  • 収益による企業の市場シェア実績

第10章 米国の微生物培養市場

  • 収益構成:実績
  • 収益実績:カテゴリー別内訳
  • 収益:これまでの推移
  • 収益:今後の予測
  • 収益による販売先のシェア実績
  • 収益による企業の市場シェア実績

第11章 主要企業の概要

  • Siemens Healthcare
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • bioMerieux S.A.
  • Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • Alere Inc.
  • Thermo Fisher Scientific Inc.
  • Immucor, Inc.
  • Ortho-Clinical Diagnostics Inc.
  • Sysmex Corporation
  • Cepheid
  • PerkinElmer, Inc.

第12章 体外診断市場:パイプライン製品

第13章 財務取引

  • 買収
  • 資産取引
  • 債券発行
  • 株式発行
  • 合併
  • 提携
  • プライベートエクイティ
  • ベンチャーファイナンシング

第14章 付録

図表

目次
Product Code: GDMEMC0286DB

GlobalData's new report, United States In Vitro Diagnostics (IVD) Market Outlook to 2024, provides key market data on the United States In Vitro Diagnostics (IVD) market. The report provides value, in millions of US dollars and volume (in units) within market categories - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics, Microbiology Culture.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for In Vitro Diagnostics (IVD) market categories - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics, Microbiology Culture.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the United States In Vitro Diagnostics (IVD) market.
  • Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Sysmex Corp, Siemens Healthcare GmbH, Beckman Coulter Inc, Thermo Fisher Scientific Inc and Others

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 19

2 Introduction 24

  • 2.1 What Is This Report About? 24
  • 2.2 In Vitro Diagnostics (IVD) Market Segmentation 24
  • 2.3 Definitions of Markets Covered in the Report 28

3 In Vitro Diagnostics Market, United States 51

  • 3.1 In Vitro Diagnostics Market, United States, Revenue ($m), 2010-2024 51
  • 3.2 In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2017 53
  • 3.3 In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2017 54
  • 3.4 In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), 2009-2023 56
  • 3.5 In Vitro Diagnostics Market, United States, Revenue ($m), 2010-2017 58
  • 3.6 In Vitro Diagnostics Market, United States, Revenue ($m), 2017-2024 60
  • 3.7 In Vitro Diagnostics Market, United States, Volume (Units), 2010-2024 62
  • 3.8 In Vitro Diagnostics Market, United States, Volume (Units), 2010-2017 64
  • 3.9 In Vitro Diagnostics Market, United States, Volume (Units), 2017-2024 66
  • 3.10 In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), 2017 68

4 Clinical Chemistry Market, United States 70

  • 4.1 Clinical Chemistry Market, United States, Revenue Mix ($m), 2017 70
  • 4.2 Clinical Chemistry Market, United States, Segment Contribution (%), 2017 71
  • 4.3 Clinical Chemistry Market, United States, Revenue ($m), 2010-2017 73
  • 4.4 Clinical Chemistry Market, United States, Revenue ($m), 2017-2024 75
  • 4.5 Clinical Chemistry Market, United States, Volume (Units), 2010-2017 109
  • 4.6 Clinical Chemistry Market, United States, Volume (Units), 2017-2024 111
  • 4.7 Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), 2017 137
  • 4.8 Clinical Chemistry Market, United States, Company Share by Revenue ($m), 2017 138

5 Genetic Testing Market, United States 140

  • 5.1 Genetic Testing Market, United States, Revenue Mix ($m), 2017 140
  • 5.2 Genetic Testing Market, United States, Segment Contribution (%), 2017 141
  • 5.3 Genetic Testing Market, United States, Revenue ($m), 2010-2017 142
  • 5.4 Genetic Testing Market, United States, Revenue ($m), 2017-2024 144
  • 5.5 Genetic Testing Market, United States, Distribution Share by Revenue ($m), 2017 146
  • 5.6 Genetic Testing Market, United States, Company Share by Revenue ($m), 2017 147

6 Hematology Market, United States 149

  • 6.1 Hematology Market, United States, Revenue Mix ($m), 2017 149
  • 6.2 Hematology Market, United States, Segment Contribution (%), 2017 150
  • 6.3 Hematology Market, United States, Revenue ($m), 2010-2017 152
  • 6.4 Hematology Market, United States, Revenue ($m), 2017-2024 154
  • 6.5 Hematology Market, United States, Volume (Units), 2010-2017 180
  • 6.6 Hematology Market, United States, Volume (Units), 2017-2024 182
  • 6.7 Hematology Market, United States, Distribution Share by Revenue ($m), 2017 200
  • 6.8 Hematology Market, United States, Company Share by Revenue ($m), 2017 201

7 Histology And Cytology Market, United States 203

  • 7.1 Histology And Cytology Market, United States, Revenue Mix ($m), 2017 203
  • 7.2 Histology And Cytology Market, United States, Segment Contribution (%), 2017 204
  • 7.3 Histology And Cytology Market, United States, Revenue ($m), 2010-2017 206
  • 7.4 Histology And Cytology Market, United States, Revenue ($m), 2017-2024 208
  • 7.5 Histology And Cytology Market, United States, Distribution Share by Revenue ($m), 2017 210
  • 7.6 Histology And Cytology Market, United States, Company Share by Revenue ($m), 2017 211

8 Immuno Chemistry Market, United States 213

  • 8.1 Immuno Chemistry Market, United States, Revenue Mix ($m), 2017 213
  • 8.2 Immuno Chemistry Market, United States, Segment Contribution (%), 2017 214
  • 8.3 Immuno Chemistry Market, United States, Revenue ($m), 2010-2017 216
  • 8.4 Immuno Chemistry Market, United States, Revenue ($m), 2017-2024 218
  • 8.5 Immuno Chemistry Market, United States, Volume (Units), 2010-2017 252
  • 8.6 Immuno Chemistry Market, United States, Volume (Units), 2017-2024 254
  • 8.7 Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), 2017 288
  • 8.8 Immuno Chemistry Market, United States, Company Share by Revenue ($m), 2017 289

9 Infectious Diagnostics Market, United States 291

  • 9.1 Infectious Diagnostics Market, United States, Revenue Mix ($m), 2017 291
  • 9.2 Infectious Diagnostics Market, United States, Segment Contribution (%), 2017 292
  • 9.3 Infectious Diagnostics Market, United States, Revenue ($m), 2010-2017 294
  • 9.4 Infectious Diagnostics Market, United States, Revenue ($m), 2017-2024 297
  • 9.5 Infectious Diagnostics Market, United States, Volume (Units), 2010-2017 344
  • 9.6 Infectious Diagnostics Market, United States, Volume (Units), 2017-2024 347
  • 9.7 Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), 2017 396
  • 9.8 Infectious Diagnostics Market, United States, Company Share by Revenue ($m), 2017 397

10 Microbiology Culture Market, United States 399

  • 10.1 Microbiology Culture Market, United States, Revenue Mix ($m), 2017 399
  • 10.2 Microbiology Culture Market, United States, Segment Contribution (%), 2017 400
  • 10.3 Microbiology Culture Market, United States, Revenue ($m), 2010-2017 402
  • 10.4 Microbiology Culture Market, United States, Revenue ($m), 2017-2024 404
  • 10.5 Microbiology Culture Market, United States, Distribution Share by Revenue ($m), 2017 414
  • 10.6 Microbiology Culture Market, United States, Company Share by Revenue ($m), 2017 415

11 Overview of Key Companies in United States, In Vitro Diagnostics Market 417

  • 11.1 F. Hoffmann-La Roche Ltd 417
  • 11.2 Beckman Coulter Inc 417
  • 11.3 Abbott Laboratories 417
  • 11.4 Becton Dickinson and Co 417
  • 11.5 Siemens Healthcare GmbH 418
  • 11.6 Thermo Fisher Scientific Inc 418
  • 11.7 Hologic Inc 418
  • 11.8 Sysmex Corp 419
  • 11.9 bioMerieux SA 419
  • 11.10 Ortho-Clinical Diagnostics Inc 419
  • 11.11 Bio-Rad Laboratories Inc 419
  • 11.12 Qiagen NV 420
  • 11.13 Alere Inc 420
  • 11.14 DiaSorin S.p.A 420

12 In Vitro Diagnostics Market Pipeline Products 421

13 Financial Deals Landscape 425

  • 13.1 Acquisition 425
  • 13.2 Asset Transactions 461
  • 13.3 Debt Offerings 477
  • 13.4 Equity Offerings 587
  • 13.5 Merger 744
  • 13.6 Partnerships 747
  • 13.7 Private Equity 925
  • 13.8 Venture Financing 936

14 Recent Developments 1084

  • 14.1 Corporate Communications 1084
  • 14.2 Financial Announcements 1356
  • 14.3 Government and Public Interest 2168
  • 14.4 Legal And Regulatory 2192
  • 14.5 Other Significant Developments 2229
  • 14.6 Product News 2367
  • 14.7 Research And Development 2618
  • 14.8 Strategy And Business Planning 2619

15 Appendix 2656

  • 15.1 Research Methodology 2657
  • 15.2 GlobalData Consulting 2661
  • 15.3 Contact Us 2662
  • 15.4 Disclaimer 2662

List of Tables

1.1 List of Tables

  • Table 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2010-2024 119
  • Table 2: In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2017 122
  • Table 3: In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), 2009-2023 124
  • Table 4: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 126
  • Table 5: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 128
  • Table 6: In Vitro Diagnostics Market, United States, Volume (Units), 2010-2024 130
  • Table 7: In Vitro Diagnostics Market, United States, Volume (Units), Historic, 2010-2017 132
  • Table 8: In Vitro Diagnostics Market, United States, Volume (Units), Forecast, 2017-2024 134
  • Table 9: In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2017 136
  • Table 10: Clinical Chemistry Market, United States, Segment Contribution (%), 2017 139
  • Table 11: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 141
  • Table 12: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 143
  • Table 13: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 145
  • Table 14: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 147
  • Table 15: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 149
  • Table 16: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 151
  • Table 17: Substrates Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 153
  • Table 18: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 155
  • Table 19: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 157
  • Table 20: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 159
  • Table 21: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 161
  • Table 22: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 163
  • Table 23: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 165
  • Table 24: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 167
  • Table 25: Substrates Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 169
  • Table 26: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 171
  • Table 27: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 173
  • Table 28: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 175
  • Table 29: Clinical Chemistry Market, United States, Volume (Units), Historic, 2010-2017 177
  • Table 30: Clinical Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 179
  • Table 31: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 181
  • Table 32: Clinical Chemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 183
  • Table 33: Enzyme Chemistry Reagents Market, United States, Volume (Units), Historic, 2010-2017 185
  • Table 34: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 187
  • Table 35: Substrates Market, United States, Volume (Units), Historic, 2010-2017 189
  • Table 36: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 191
  • Table 37: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 193
  • Table 38: Clinical Chemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 195
  • Table 39: Enzyme Chemistry Reagents Market, United States, Volume (Units), Forecast, 2017-2024 197
  • Table 40: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 199
  • Table 41: Substrates Market, United States, Volume (Units), Forecast, 2017-2024 201
  • Table 42: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 203
  • Table 43: Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016-2017 204
  • Table 44: Clinical Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2017 206
  • Table 45: Genetic Testing Market, United States, Segment Contribution (%), 2017 208
  • Table 46: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 210
  • Table 47: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 212
  • Table 48: Genetic Testing Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 213
  • Table 49: Genetic Testing Market, United States, Company Share by Revenue ($m), USD Constant, 2017 215
  • Table 50: Hematology Market, United States, Segment Contribution (%), 2017 218
  • Table 51: Hematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 220
  • Table 52: Hematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 222
  • Table 53: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 224
  • Table 54: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 226
  • Table 55: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 228
  • Table 56: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 230
  • Table 57: Hemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 232
  • Table 58: Immunohematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 234
  • Table 59: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 236
  • Table 60: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 238
  • Table 61: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 240
  • Table 62: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 242
  • Table 63: Hemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 244
  • Table 64: Immunohematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 246
  • Table 65: Hematology Market, United States, Volume (Units), Historic, 2010-2017 248
  • Table 66: Hematology Market, United States, Volume (Units), Forecast, 2017-2024 250
  • Table 67: Hematology Analyzers Market, United States, Volume (Units), Historic, 2010-2017 252
  • Table 68: Hematology Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 254
  • Table 69: Hematology Reagents Market, United States, Volume (Units), Historic, 2010-2017 256
  • Table 70: Hemostasis Market, United States, Volume (Units), Historic, 2010-2017 258
  • Table 71: Hematology Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 260
  • Table 72: Hematology Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 262
  • Table 73: Hematology Reagents Market, United States, Volume (Units), Forecast, 2017-2024 264
  • Table 74: Hemostasis Market, United States, Volume (Units), Forecast, 2017-2024 266
  • Table 75: Hematology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 267
  • Table 76: Hematology Market, United States, Company Share by Revenue ($m), USD Constant, 2017 269
  • Table 77: Histology And Cytology Market, United States, Segment Contribution (%), 2017 272
  • Table 78: Histology And Cytology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 274
  • Table 79: Histology And Cytology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 276
  • Table 80: Histology And Cytology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 277
  • Table 81: Histology And Cytology Market, United States, Company Share by Revenue ($m), USD Constant, 2017 279
  • Table 82: Immuno Chemistry Market, United States, Segment Contribution (%), 2017 282
  • Table 83: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 284
  • Table 84: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 286
  • Table 85: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 288
  • Table 86: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 290
  • Table 87: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 292
  • Table 88: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 294
  • Table 89: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 296
  • Table 90: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 298
  • Table 91: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 300
  • Table 92: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 302
  • Table 93: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 304
  • Table 94: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 306
  • Table 95: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 308
  • Table 96: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 310
  • Table 97: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 312
  • Table 98: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 314
  • Table 99: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 316
  • Table 100: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 318
  • Table 101: Immuno Chemistry Market, United States, Volume (Units), Historic, 2010-2017 320
  • Table 102: Immuno Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 322
  • Table 103: Complement Deficiency Tests Market, United States, Volume (Units), Historic, 2010-2017 324
  • Table 104: Diabetes Assays Market, United States, Volume (Units), Historic, 2010-2017 326
  • Table 105: Disease Specific Immunochemistry Market, United States, Volume (Units), Historic, 2010-2017 328
  • Table 106: Endocrinology Tests Market, United States, Volume (Units), Historic, 2010-2017 330
  • Table 107: IgE Allergy Blood Tests Market, United States, Volume (Units), Historic, 2010-2017 332
  • Table 108: Immunochemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 334
  • Table 109: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 336
  • Table 110: Vitamins Tests Market, United States, Volume (Units), Historic, 2010-2017 338
  • Table 111: Complement Deficiency Tests Market, United States, Volume (Units), Forecast, 2017-2024 340
  • Table 112: Diabetes Assays Market, United States, Volume (Units), Forecast, 2017-2024 342
  • Table 113: Disease Specific Immunochemistry Market, United States, Volume (Units), Forecast, 2017-2024 344
  • Table 114: Endocrinology Tests Market, United States, Volume (Units), Forecast, 2017-2024 346
  • Table 115: IgE Allergy Blood Tests Market, United States, Volume (Units), Forecast, 2017-2024 348
  • Table 116: Immunochemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 350
  • Table 117: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 352
  • Table 118: Vitamins Tests Market, United States, Volume (Units), Forecast, 2017-2024 354
  • Table 119: Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 355
  • Table 120: Immuno Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2017 357
  • Table 121: Infectious Diagnostics Market, United States, Segment Contribution (%), 2017 360
  • Table 122: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 362
  • Table 123: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 365
  • Table 124: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 368
  • Table 125: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 370
  • Table 126: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 372
  • Table 127: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 374
  • Table 128: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 376
  • Table 129: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 378
  • Table 130: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 380
  • Table 131: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 382
  • Table 132: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 384
  • Table 133: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 386

List of Figures

1.2 List of Figures

  • Figure 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2010-2024 118
  • Figure 2: In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2017 120
  • Figure 3: In Vitro Diagnostics Market, United States, Category Contribution (%), 2017 121
  • Figure 4: In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), 2009-2023 123
  • Figure 5: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 125
  • Figure 6: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 127
  • Figure 7: In Vitro Diagnostics Market, United States, Volume (Units), 2010-2024 129
  • Figure 8: In Vitro Diagnostics Market, United States, Volume (Units), Historic, 2010-2017 131
  • Figure 9: In Vitro Diagnostics Market, United States, Volume (Units), Forecast, 2017-2024 133
  • Figure 10: In Vitro Diagnostics Market, United States, Company Share (%) 2017 135
  • Figure 11: Clinical Chemistry Market, United States, Revenue Mix ($m), 2017 137
  • Figure 12: Clinical Chemistry Market, United States, Segment Contribution (%), 2017 138
  • Figure 13: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 140
  • Figure 14: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 142
  • Figure 15: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 144
  • Figure 16: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 146
  • Figure 17: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 148
  • Figure 18: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 150
  • Figure 19: Substrates Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 152
  • Figure 20: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 154
  • Figure 21: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 156
  • Figure 22: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 158
  • Figure 23: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 160
  • Figure 24: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 162
  • Figure 25: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 164
  • Figure 26: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 166
  • Figure 27: Substrates Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 168
  • Figure 28: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 170
  • Figure 29: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 172
  • Figure 30: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 174
  • Figure 31: Clinical Chemistry Market, United States, Volume (Units), Historic, 2010-2017 176
  • Figure 32: Clinical Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 178
  • Figure 33: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 180
  • Figure 34: Clinical Chemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 182
  • Figure 35: Enzyme Chemistry Reagents Market, United States, Volume (Units), Historic, 2010-2017 184
  • Figure 36: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 186
  • Figure 37: Substrates Market, United States, Volume (Units), Historic, 2010-2017 188
  • Figure 38: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 190
  • Figure 39: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 192
  • Figure 40: Clinical Chemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 194
  • Figure 41: Enzyme Chemistry Reagents Market, United States, Volume (Units), Forecast, 2017-2024 196
  • Figure 42: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 198
  • Figure 43: Substrates Market, United States, Volume (Units), Forecast, 2017-2024 200
  • Figure 44: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 202
  • Figure 45: Clinical Chemistry Market, United States, Company Share (%) 2017 205
  • Figure 46: Genetic Testing Market, United States, Revenue Mix ($m), 2017 207
  • Figure 47: Genetic Testing Market, United States, Segment Contribution (%), 2017 208
  • Figure 48: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 209
  • Figure 49: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 211
  • Figure 50: Genetic Testing Market, United States, Company Share (%) 2017 214
  • Figure 51: Hematology Market, United States, Revenue Mix ($m), 2017 216
  • Figure 52: Hematology Market, United States, Segment Contribution (%), 2017 217
  • Figure 53: Hematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 219
  • Figure 54: Hematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 221
  • Figure 55: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 223
  • Figure 56: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 225
  • Figure 57: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 227
  • Figure 58: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 229
  • Figure 59: Hemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 231
  • Figure 60: Immunohematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 233
  • Figure 61: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 235
  • Figure 62: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 237
  • Figure 63: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 239
  • Figure 64: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 241
  • Figure 65: Hemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 243
  • Figure 66: Immunohematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 245
  • Figure 67: Hematology Market, United States, Volume (Units), Historic, 2010-2017 247
  • Figure 68: Hematology Market, United States, Volume (Units), Forecast, 2017-2024 249
  • Figure 69: Hematology Analyzers Market, United States, Volume (Units), Historic, 2010-2017 251
  • Figure 70: Hematology Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 253
  • Figure 71: Hematology Reagents Market, United States, Volume (Units), Historic, 2010-2017 255
  • Figure 72: Hemostasis Market, United States, Volume (Units), Historic, 2010-2017 257
  • Figure 73: Hematology Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 259
  • Figure 74: Hematology Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 261
  • Figure 75: Hematology Reagents Market, United States, Volume (Units), Forecast, 2017-2024 263
  • Figure 76: Hemostasis Market, United States, Volume (Units), Forecast, 2017-2024 265
  • Figure 77: Hematology Market, United States, Company Share (%) 2017 268
  • Figure 78: Histology And Cytology Market, United States, Revenue Mix ($m), 2017 270
  • Figure 79: Histology And Cytology Market, United States, Segment Contribution (%), 2017 271
  • Figure 80: Histology And Cytology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 273
  • Figure 81: Histology And Cytology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 275
  • Figure 82: Histology And Cytology Market, United States, Company Share (%) 2017 278
  • Figure 83: Immuno Chemistry Market, United States, Revenue Mix ($m), 2017 280
  • Figure 84: Immuno Chemistry Market, United States, Segment Contribution (%), 2017 281
  • Figure 85: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 283
  • Figure 86: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 285
  • Figure 87: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 287
  • Figure 88: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 289
  • Figure 89: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 291
  • Figure 90: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 293
  • Figure 91: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 295
  • Figure 92: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 297
  • Figure 93: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 299
  • Figure 94: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 301
  • Figure 95: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 303
  • Figure 96: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 305
  • Figure 97: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 307
  • Figure 98: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 309
  • Figure 99: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 311
  • Figure 100: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 313
  • Figure 101: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 315
  • Figure 102: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 317
  • Figure 103: Immuno Chemistry Market, United States, Volume (Units), Historic, 2010-2017 319
  • Figure 104: Immuno Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 321
  • Figure 105: Complement Deficiency Tests Market, United States, Volume (Units), Historic, 2010-2017 323
  • Figure 106: Diabetes Assays Market, United States, Volume (Units), Historic, 2010-2017 325
  • Figure 107: Disease Specific Immunochemistry Market, United States, Volume (Units), Historic, 2010-2017 327
  • Figure 108: Endocrinology Tests Market, United States, Volume (Units), Historic, 2010-2017 329
  • Figure 109: IgE Allergy Blood Tests Market, United States, Volume (Units), Historic, 2010-2017 331
  • Figure 110: Immunochemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 333
  • Figure 111: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 335
  • Figure 112: Vitamins Tests Market, United States, Volume (Units), Historic, 2010-2017 337
  • Figure 113: Complement Deficiency Tests Market, United States, Volume (Units), Forecast, 2017-2024 339
  • Figure 114: Diabetes Assays Market, United States, Volume (Units), Forecast, 2017-2024 341
  • Figure 115: Disease Specific Immunochemistry Market, United States, Volume (Units), Forecast, 2017-2024 343
  • Figure 116: Endocrinology Tests Market, United States, Volume (Units), Forecast, 2017-2024 345
  • Figure 117: IgE Allergy Blood Tests Market, United States, Volume (Units), Forecast, 2017-2024 347
  • Figure 118: Immunochemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 349
  • Figure 119: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 351
Back to Top